On a year to date basis, sales for fiscal 2009 were CAD3,019,163 compared to CAD2,755,976 for fiscal 2008; which was a 10% increase over 2008. Our flagship product, the FAST1 Intraosseous Infusion System, is the largest selling Sternal IO System with over 190,000 units shipped to-date.
Cost of sales for the second quarter of fiscal 2009 was CAD412,229 providing a gross margin of CAD972,948 or 70%. Total operating expenses for the quarter increased to CAD958,627, compared to CAD705,675 for the second quarter of fiscal 2008. On a percentage basis, operating expenses increased from 49% to 69% of sales for second quarter of 2009.
